What is the market price of Isatuximab in 2026?

Isatuximab (Isatuximab) has been approved for marketing in China and is mainly used for the treatment of multiple myeloma. This drug has been included in the reimbursement scope of domestic medical insurance, so patients need to bear the full cost when purchasing it at their own expense in China. According to the latest market information, the domestic price of isatuximab is about more than 12,000 yuan per box, and the specific price will fluctuate slightly depending on hospitals and pharmacies. Patients need to fully understand the cost situation before use in order to make a financial budget and medication plan.

In overseas markets, the price of the original drug of isatuximab is relatively high. Taking the US version as an example, the price per box is about more than 3,000 US dollars, which is equivalent to more than 20,000 yuan in RMB. Actual costs may vary due to differences in exchange rates and import channels. There are currently no generic drugs on the market in overseas markets, so the prices are relatively fixed. If patients purchase drugs through overseas channels, they need to pay attention to factors such as transportation and customs policies.

At present, the market supply of isatuximab mainly relies on hospital pharmacies and formal import channels. There are no related generic drugs launched in China, which means that domestic patients can only rely on the original drug for treatment for the time being. In long-term treatment, each medication may require multiple bottles of medication, resulting in higher cumulative costs. Therefore, before taking medication, patients should fully communicate with their doctors about the treatment plan and medication cycle based on their financial affordability to ensure the sustainability of treatment.

In addition, patients should pay attention to drug storage conditions and medication specifications when purchasing and using drugs. Isatuximab is an intravenous injection preparation and needs to be operated by professional medical staff. At the same time, adverse reactions, such as injection site reactions, hematological changes, etc., need to be monitored during use. Taken together, isatuximab has good clinical efficacy. However, due to the high price and lack of generic drugs, patients need to reasonably plan the cost and treatment plan to obtain the best treatment effect.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC8497289/